Steatosis from de novo lipogenesis in the liver, as well as influx of fatty acids from peripheral tissue (as seen in metabolic syndrome, insulin insensitivity, and obesity), leads to lipotoxicity, which promotes hepatocyte apoptosis and the release of damage associated molecular patterns (DAMPs). This evidence concerns the gene INS and steatosis.